Classification and Personalized Prognosis in Myeloproliferative Neoplasms

Using 63 clinical and genomic variables, researchers generated prognostic models to personalize clinical outcome predictions for patients with essential thrombocythemia, polycythemia vera, myelofibrosis, and other MPNs, and study results demonstrated that these models significantly improved prediction accuracy.

 New England Journal of Medicine

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.